logo
Plus   Neg
Share
Email

Allergan: FDA Approves BOTOX For Pediatric Patients - Quick Facts

Allergan plc (AGN) said the U.S. FDA has approved the company's supplemental Biologics License Application, or sBLA, for BOTOX for the treatment of pediatric patients with lower limb spasticity, excluding spasticity caused by cerebral palsy. The company noted that the approval marks 11th BOTOX therapeutic indication.

The FDA approval is based on a phase 3 study evaluating the safety and efficacy of BOTOX in more than 300 pediatric patients aged two to 17 years old being treated for lower limb spasticity.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Biotech company Illumina agreed to buy healthcare company GRAIL, Inc. in a cash and stock deal valued at $8 billion. This includes $3.5 billion in cash and $4.5 billion in shares of Illumina common stock. GRAIL focuses on multi-cancer early detection from blood. It is in the process of developing the technology and providing clinical data required to launch the Galleri multi-cancer screening test. Oracle and Walmart have tentatively agreed to acquire 20% of the newly formed TikTok Global business, the companies said in a statement. Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030.
Follow RTT